In this podcast, Dr. Michael Williams discusses research about treating several types of lymphoma presented at last month’s ASH Annual Meeting.
Dr. Norah Lynn Henry discusses 4 research findings from the 2019 San Antonio Breast Cancer Symposium for the treatment of various types of breast cancer.
In this podcast, Dr. Ryan Nipp and Dr. Electra Paskett discuss why clinical trial participation is so important and which aspects of clinical trials might be holding patients back from joining one.
In these “Your Stories” podcasts from Conquer Cancer, the ASCO Foundation, individuals share their experiences with clinical trials.
Dr. Ricardo Cubedo describes 3 research highlights from the ESMO 2019 Congress, including targeted therapy for ovarian cancer, immunotherapy for lung cancer, and more study data on targeted tumor-agnostic treatment.
Blood Tests to Find Cancer and Precision Radiation Therapy: Research from the ASCO Breakthrough Global Summit
Research from the ASCO Breakthrough global summit highlights innovations in blood tests to find cancer and using genetic markers to personalize the use of radiation therapy.
Learn what “treatment switching” in clinical trials is and what to ask about it before you join a clinical trial.
In this podcast interview, ASCO experts talk about new research on patient participation in clinical trials.
The "Your Stories" podcast series from Conquer Cancer, the ASCO Foundation, provides insight into what it’s like to conquer cancer from different viewpoints. The podcasts featured here touch on how families cope with a cancer diagnosis.
ASCO Annual Meeting 2019: Laparoscopic Surgery for Metastatic Colorectal Cancer, Expanding Eligibility Criteria for Advanced Non-Small Cell Lung Cancer, and a New Targeted Therapy for Advanced Bladder Cancer
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include minimally invasive surgery for liver metastases in colorectal cancer, expanding clinical trial eligibility criteria for non-small cell lung cancer, and a new targeted therapy for advanced bladder cancer.